Cytotoxic and Antimetastatic Activity of Hesperetin and Doxorubicin Combination Toward Her2 Expressing Breast Cancer Cells

OBJECTIVE: This study aimed to explore Hesperetin (Hst) potency as a co-chemotherapeutics agent combined with Doxorubicin (Dox), particularly cytotoxic and antimetastasis effects toward MCF-7/HER2 cells. METHODS: The cytotoxic effects were measured under MTT assay. The flowcytometry analysis was use...

Descripción completa

Detalles Bibliográficos
Autores principales: Nurhayati, Ika Putri, Khumaira, Annisa, Ilmawati, Gagas Pradani Nur, Meiyanto, Edy, Hermawan, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541862/
https://www.ncbi.nlm.nih.gov/pubmed/32458631
http://dx.doi.org/10.31557/APJCP.2020.21.5.1259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541862/
https://www.ncbi.nlm.nih.gov/pubmed/32458631
http://dx.doi.org/10.31557/APJCP.2020.21.5.1259

Ejemplares similares